TY - JOUR
T1 - Accelerated aging in adults with knee osteoarthritis pain
T2 - Consideration for frequency, intensity, time, and total pain sites
AU - Sibille, Kimberly T.
AU - Chen, Huaihou
AU - Bartley, Emily J.
AU - Riley, Joseph
AU - Glover, Toni L.
AU - King, Christopher D.
AU - Zhang, Hang
AU - Cruz-Almeida, Yenisel
AU - Goodin, Burel R.
AU - Sotolongo, Adriana
AU - Petrov, Megan
AU - Herbert, Matthew
AU - Bulls, Hailey W.
AU - Edberg, Jeffrey C.
AU - Staud, Roland
AU - Redden, David
AU - Bradley, Laurence A.
AU - Fillingim, Roger B.
N1 - Funding Information:
Supported by the National Institutes of Health/National Institute on Aging (R37AG033906 and OppNet AG0333906 07S1), the University of Florida Clinical and Translational Science Institute (UL1TR000064), and the University of Alabama at Birmingham Center for Clinical and Translational Science (UL1TR000165); the American Pain Society Future Leaders in Pain Research Grant awarded to K. T. Sibille. K. T. Sibille is funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases K23AR062099, E.J. Bartley is funded by the National Institute on Aging K99AG052642-01, C. D. King by the National Institute on Dental and Craniofacial Research K99DE022368, and Y. Cruz-Almeida is funded by the National Institute on Aging K01AG048259. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The International Association for the Study of Pain.
PY - 2017/5/1
Y1 - 2017/5/1
N2 - Introduction: Individuals with osteoarthritis (OA) show increased morbidity and mortality. Telomere length, a measure of cellular aging, predicts increased morbidity and mortality. Telomeres shorten with persisting biological and psychosocial stress. Living with chronic OA pain is stressful. Previous research exploring telomere length in people with OA has produced inconsistent results. Considering pain severity may clarify the relationship between OA and telomeres. Objectives: We hypothesized that individuals with high OA chronic pain severity would have shorter telomeres than those with no or low chronic pain severity. Methods: One hundred thirty-six adults, ages 45 to 85 years old, with and without symptomatic knee OA were included in the analysis. Peripheral blood leukocyte telomere length was measured, and demographic, clinical, and functional data were collected. Participants were categorized into 5 pain severity groups based on an additive index of frequency, intensity, time or duration, and total number of pain sites (FITT). Covariates included age, sex, race or ethnicity, study site, and knee pain status. Results: The no or low chronic pain severity group had significantly longer telomeres compared with the high pain severity group, P 5 0.025. A significant chronic pain severity dose response emerged for telomere length, P 5 0.034. The FITT chronic pain severity index was highly correlated with the clinical and functional OA pain measures. However, individual clinical and functional measures were not associated with telomere length. Conclusion: Results demonstrate accelerated cellular aging with high knee OA chronic pain severity and provide evidence for the potential utility of the FITT chronic pain severity index in capturing the biological burden of chronic pain.
AB - Introduction: Individuals with osteoarthritis (OA) show increased morbidity and mortality. Telomere length, a measure of cellular aging, predicts increased morbidity and mortality. Telomeres shorten with persisting biological and psychosocial stress. Living with chronic OA pain is stressful. Previous research exploring telomere length in people with OA has produced inconsistent results. Considering pain severity may clarify the relationship between OA and telomeres. Objectives: We hypothesized that individuals with high OA chronic pain severity would have shorter telomeres than those with no or low chronic pain severity. Methods: One hundred thirty-six adults, ages 45 to 85 years old, with and without symptomatic knee OA were included in the analysis. Peripheral blood leukocyte telomere length was measured, and demographic, clinical, and functional data were collected. Participants were categorized into 5 pain severity groups based on an additive index of frequency, intensity, time or duration, and total number of pain sites (FITT). Covariates included age, sex, race or ethnicity, study site, and knee pain status. Results: The no or low chronic pain severity group had significantly longer telomeres compared with the high pain severity group, P 5 0.025. A significant chronic pain severity dose response emerged for telomere length, P 5 0.034. The FITT chronic pain severity index was highly correlated with the clinical and functional OA pain measures. However, individual clinical and functional measures were not associated with telomere length. Conclusion: Results demonstrate accelerated cellular aging with high knee OA chronic pain severity and provide evidence for the potential utility of the FITT chronic pain severity index in capturing the biological burden of chronic pain.
KW - Cellular aging
KW - Osteoarthritis
KW - Pain severity
KW - Stress
KW - Telomere length
UR - http://www.scopus.com/inward/record.url?scp=85055697066&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055697066&partnerID=8YFLogxK
U2 - 10.1097/PR9.0000000000000591
DO - 10.1097/PR9.0000000000000591
M3 - Article
AN - SCOPUS:85055697066
SN - 2471-2531
VL - 2
JO - Pain Reports
JF - Pain Reports
IS - 3
M1 - e591
ER -